Header Logo

Connection

MARGARET SPITZ to Risk

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Risk.
MARGARET SPITZ
Connection Strength
0.997
Risk
  1. The development of a comprehensive, institution-based patient risk evaluation program: I. Development, content, and data management. Am J Prev Med. 1988 Jul-Aug; 4(4):183-7.
    View in: PubMed
    Score: 0.064
  2. The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med. 1988 Jul-Aug; 4(4):188-93.
    View in: PubMed
    Score: 0.064
  3. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007 Jul 01; 67(13):6520-7.
    View in: PubMed
    Score: 0.060
  4. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):158-61.
    View in: PubMed
    Score: 0.054
  5. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004 Dec 15; 101(12):2837-42.
    View in: PubMed
    Score: 0.050
  6. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
    View in: PubMed
    Score: 0.048
  7. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9.
    View in: PubMed
    Score: 0.033
  8. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8.
    View in: PubMed
    Score: 0.032
  9. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine. 2016 Sep; 11:219-226.
    View in: PubMed
    Score: 0.028
  10. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr. 1995; (18):29-33.
    View in: PubMed
    Score: 0.025
  11. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.024
  12. Mutagen sensitivity as a marker of cancer risk. Cancer Detect Prev. 1994; 18(4):299-303.
    View in: PubMed
    Score: 0.023
  13. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.
    View in: PubMed
    Score: 0.022
  14. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
    View in: PubMed
    Score: 0.022
  15. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012 Nov 15; 21(22):4980-95.
    View in: PubMed
    Score: 0.021
  16. Chapter 11: Rice-MD Anderson lung cancer model. Risk Anal. 2012 Jul; 32 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.021
  17. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.021
  18. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.021
  19. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control. 2012 Mar; 23(3):487-96.
    View in: PubMed
    Score: 0.021
  20. A smoking-based carcinogenesis model for lung cancer risk prediction. Int J Cancer. 2011 Oct 15; 129(8):1907-13.
    View in: PubMed
    Score: 0.019
  21. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
    View in: PubMed
    Score: 0.019
  22. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23.
    View in: PubMed
    Score: 0.019
  23. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62.
    View in: PubMed
    Score: 0.018
  24. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009 Aug 15; 69(16):6633-41.
    View in: PubMed
    Score: 0.017
  25. Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer. 2007 Mar 15; 109(6):1157-63.
    View in: PubMed
    Score: 0.015
  26. Dietary zinc, copper and selenium, and risk of lung cancer. Int J Cancer. 2007 Mar 01; 120(5):1108-15.
    View in: PubMed
    Score: 0.015
  27. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
    View in: PubMed
    Score: 0.014
  28. Questionable relationship between cholecystectomy and colon cancer. J Surg Oncol. 1985 Sep; 30(1):6-9.
    View in: PubMed
    Score: 0.013
  29. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
    View in: PubMed
    Score: 0.013
  30. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.013
  31. Multiple primary cancer risk in patients with major salivary gland carcinoma. Ann Otol Rhinol Laryngol. 1985 Mar-Apr; 94(2 Pt 1):129-32.
    View in: PubMed
    Score: 0.013
  32. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005 Mar; 15(3):159-65.
    View in: PubMed
    Score: 0.013
  33. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89.
    View in: PubMed
    Score: 0.012
  34. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer. 1984 Nov 01; 54(9):1854-9.
    View in: PubMed
    Score: 0.012
  35. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.012
  36. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984 Jan; 110(1):45-9.
    View in: PubMed
    Score: 0.012
  37. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61.
    View in: PubMed
    Score: 0.011
  38. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.011
  39. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7.
    View in: PubMed
    Score: 0.011
  40. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002 Sep 26; 183(2):123-30.
    View in: PubMed
    Score: 0.011
  41. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37.
    View in: PubMed
    Score: 0.011
  42. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6.
    View in: PubMed
    Score: 0.008
  43. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst. 1997 Feb 05; 89(3):199-211.
    View in: PubMed
    Score: 0.007
  44. Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 1994 Jun; 3(4):285-8.
    View in: PubMed
    Score: 0.006
  45. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):467-76.
    View in: PubMed
    Score: 0.004
  46. Childhood nervous system tumors--an evaluation of the association with paternal occupational exposure to hydrocarbons. Am J Epidemiol. 1987 Oct; 126(4):605-13.
    View in: PubMed
    Score: 0.004
  47. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987 Aug; 79(2):259-62.
    View in: PubMed
    Score: 0.004
  48. Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. J Natl Cancer Inst. 1987 May; 78(5):881-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.